• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常温区域灌注可改善心脏死亡后供体肝脏、肾脏和胰腺移植的利用率及预后。

Normothermic Regional Perfusion Can Improve Both Utilization and Outcomes in DCD Liver, Kidney, and Pancreas Transplantation.

作者信息

Bekki Yuki, Croome Kristopher P, Myers Bryan, Sasaki Kazunari, Tomiyama Koji

机构信息

Recanati-Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York City, NY.

Department of Transplant, Mayo Clinic Florida, Jacksonville, FL.

出版信息

Transplant Direct. 2023 Feb 17;9(3):e1450. doi: 10.1097/TXD.0000000000001450. eCollection 2023 Mar.

DOI:10.1097/TXD.0000000000001450
PMID:36845854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9945290/
Abstract

UNLABELLED

Normothermic regional perfusion (NRP) has gained widespread adoption in multiple European countries. The aim of this study was to examine the influence of thoracoabdominal-NRP (TA-NRP) on the utilization and outcomes of liver, kidney, and pancreas transplantation in the United States.

METHODS

Using the US national registry data between 2020 and 2021, donation after circulatory death (DCD) donors were separated into 2 groups: DCD with TA-NRP and without TA-NRP. There were 5234 DCD donors; among them 34 donors were with TA-NRP. After 1:4 propensity score matching, the utilization rates were compared between DCD with and without TA-NRP.

RESULTS

Although the utilization rates of kidney and pancreas were comparable ( = 0.71 and  = 0.06, 94.1% versus 95.6% and 8.8% versus 2.2%, respectively), that of liver in DCD with TA-NRP was significantly higher ( < 0.001; 70.6% versus 39.0%). Among 24 liver transplantations, 62 kidney transplantations, and 3 pancreas transplantations from DCD with TA-NRP, there were 2 liver grafts and 1 kidney graft that failed within 1 y after transplantation.

CONCLUSIONS

TA-NRP in the United States significantly increased the utilization rate of abdominal organs from DCD donors with comparable outcomes after transplantation. Increasing use of NRP may expand the donor pool without compromising transplant outcomes.

摘要

未标注

常温区域灌注(NRP)已在多个欧洲国家广泛应用。本研究的目的是探讨胸腹常温区域灌注(TA-NRP)对美国肝脏、肾脏和胰腺移植的利用情况及结局的影响。

方法

利用2020年至2021年美国国家登记数据,将循环死亡后捐赠(DCD)供体分为两组:接受TA-NRP的DCD供体和未接受TA-NRP的DCD供体。共有5234名DCD供体;其中34名供体接受了TA-NRP。经过1:4倾向评分匹配后,比较接受和未接受TA-NRP的DCD供体的利用率。

结果

虽然肾脏和胰腺的利用率相当(P=0.71和P=0.06,分别为94.1%对95.6%和8.8%对2.2%),但接受TA-NRP的DCD供体肝脏的利用率显著更高(P<0.001;70.6%对39.0%)。在接受TA-NRP的DCD供体进行的24例肝脏移植、62例肾脏移植和3例胰腺移植中,有2例肝脏移植物和1例肾脏移植物在移植后1年内失败。

结论

美国的TA-NRP显著提高了DCD供体腹部器官的利用率,移植后结局相当。增加NRP的使用可能会扩大供体库,而不影响移植结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/139fced7690e/txd-9-e1450-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/29d0c9430b30/txd-9-e1450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/4d9769040655/txd-9-e1450-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/139fced7690e/txd-9-e1450-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/29d0c9430b30/txd-9-e1450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/4d9769040655/txd-9-e1450-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285b/9945290/139fced7690e/txd-9-e1450-g003.jpg

相似文献

1
Normothermic Regional Perfusion Can Improve Both Utilization and Outcomes in DCD Liver, Kidney, and Pancreas Transplantation.常温区域灌注可改善心脏死亡后供体肝脏、肾脏和胰腺移植的利用率及预后。
Transplant Direct. 2023 Feb 17;9(3):e1450. doi: 10.1097/TXD.0000000000001450. eCollection 2023 Mar.
2
Six-month abdominal transplant recipient outcomes from donation after circulatory death heart donors: A retrospective analysis by procurement technique.移植后 6 个月腹部器官受者结局:供体心死亡后循环标准下的回顾性分析:按获取技术的分类
Am J Transplant. 2023 Jul;23(7):987-995. doi: 10.1016/j.ajt.2023.04.021. Epub 2023 Apr 21.
3
Kidney Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion: The Largest Report of the United States Experience.使用胸腹腔常温区域灌注实现心跳死亡后的肾脏捐献:美国最大规模经验报告。
Transplantation. 2024 Feb 1;108(2):516-523. doi: 10.1097/TP.0000000000004801. Epub 2023 Sep 11.
4
Single center utilization and post-transplant outcomes of thoracoabdominal normothermic regional perfusion deceased cardiac donor organs.单中心应用及移植后胸腹常温区域性灌注供心的结局。
Clin Transplant. 2024 Mar;38(3):e15269. doi: 10.1111/ctr.15269.
5
Early patient and liver allograft outcomes from donation after circulatory death donors using thoracoabdominal normothermic regional: a multi-center observational experience.使用胸腹常温局部灌注技术的循环死亡后器官捐献供体的早期患者及肝脏移植结果:一项多中心观察性研究
Front Transplant. 2023 Sep 11;2:1184620. doi: 10.3389/frtra.2023.1184620. eCollection 2023.
6
Improved Early Post-Transplant Outcomes and Organ Use in Kidney Transplant Using Normothermic Regional Perfusion for Donation after Circulatory Death: National Experience in the US.在美国的全国经验:使用常温局部灌注用于循环死亡后器官捐献的肾脏移植中,移植后早期结局及器官利用情况得到改善。
J Am Coll Surg. 2024 Jan 1;238(1):107-118. doi: 10.1097/XCS.0000000000000880. Epub 2023 Sep 29.
7
Lung recovery utilizing thoracoabdominal normothermic regional perfusion during donation after circulatory death: The Colorado experience.循环死亡后捐赠期间利用胸腹常温区域灌注进行肺恢复:科罗拉多州的经验。
JTCVS Tech. 2023 Oct 5;22:350-358. doi: 10.1016/j.xjtc.2023.09.027. eCollection 2023 Dec.
8
Preserved 2-y Liver Transplant Outcomes Following Simultaneous Thoracoabdominal DCD Organ Procurement Despite Effects on Liver Utilization Rate.尽管对肝脏利用率有影响,但同期胸腹联合心脏死亡后器官捐献(DCD)器官获取后2年肝脏移植结局良好。
Transplant Direct. 2023 Oct 20;9(11):e1528. doi: 10.1097/TXD.0000000000001528. eCollection 2023 Nov.
9
Early United States experience with lung donation after circulatory death using thoracoabdominal normothermic regional perfusion.美国早期使用胸腹腔常温区域灌注进行循环死亡后肺捐献的经验。
J Heart Lung Transplant. 2023 Jun;42(6):693-696. doi: 10.1016/j.healun.2023.03.001. Epub 2023 Mar 8.
10
Normothermic Regional Perfusion is an Emerging Cost-Effective Alternative in Donation After Circulatory Death (DCD) in Heart Transplantation.常温区域灌注是心脏移植中循环性死亡后器官捐献(DCD)的一种新兴的具有成本效益的替代方案。
Cureus. 2022 Jun 29;14(6):e26437. doi: 10.7759/cureus.26437. eCollection 2022 Jun.

引用本文的文献

1
Update on Organ Allocation and Liver Transplantation.器官分配与肝移植的最新进展
Gastroenterol Hepatol (N Y). 2025 Jul;21(7):424-430.
2
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion.在先进灌注时代美国已故捐赠者肝脏利用情况的地域差异。
Liver Transpl. 2025 Jul 15. doi: 10.1097/LVT.0000000000000687.
3
Recent Strategies to Attenuate Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Narrative Review.肝移植后减轻肝细胞癌复发的近期策略:一项叙述性综述

本文引用的文献

1
Improved Organ Utilization and Better Transplant Outcomes With In Situ Normothermic Regional Perfusion in Controlled Donation After Circulatory Death.在循环性死亡后控制性捐赠中采用原位常温区域灌注改善器官利用和提高移植效果。
Transplantation. 2023 Feb 1;107(2):438-448. doi: 10.1097/TP.0000000000004280. Epub 2023 Jan 26.
2
Normothermic Regional Perfusion is an Emerging Cost-Effective Alternative in Donation After Circulatory Death (DCD) in Heart Transplantation.常温区域灌注是心脏移植中循环性死亡后器官捐献(DCD)的一种新兴的具有成本效益的替代方案。
Cureus. 2022 Jun 29;14(6):e26437. doi: 10.7759/cureus.26437. eCollection 2022 Jun.
3
Cancers (Basel). 2025 May 13;17(10):1650. doi: 10.3390/cancers17101650.
4
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies.作为移植器官常温灌注生物标志物和治疗靶点的程序性细胞死亡和损伤相关分子模式。第2部分:实施策略。
Front Transplant. 2025 Apr 24;4:1575703. doi: 10.3389/frtra.2025.1575703. eCollection 2025.
5
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ.调节性细胞死亡和损伤相关分子模式作为移植器官常温灌注中的生物标志物和治疗靶点。第1部分:它们从供体器官损伤中出现的情况。
Front Transplant. 2025 Apr 24;4:1571516. doi: 10.3389/frtra.2025.1571516. eCollection 2025.
6
Liver transplant program utilization of donation after circulatory death liver grafts by procurement technique and storage modality: a survey of US liver transplant surgical directors.美国肝脏移植外科主任调查:按获取技术和保存方式划分的循环死亡后肝脏移植捐献肝脏在肝脏移植项目中的利用情况
Proc (Bayl Univ Med Cent). 2025 Feb 5;38(3):253-258. doi: 10.1080/08998280.2025.2457899. eCollection 2025.
7
Novel pulmonary abdominal normothermic regional perfusion circuit for simultaneous in-donor evaluation and preservation of lungs and abdominal organs in donation after circulatory death.用于循环性死亡后供体肺和腹部器官同步评估及保存的新型肺腹常温区域灌注回路。
Gen Thorac Cardiovasc Surg. 2025 Mar 16. doi: 10.1007/s11748-025-02137-y.
8
Donor after circulatory death in pancreas transplantation: a scoping review of the literature.胰腺移植中循环死亡后供体:文献的范围综述
Front Transplant. 2025 Feb 25;4:1517354. doi: 10.3389/frtra.2025.1517354. eCollection 2025.
9
Thoracoabdominal Normothermic Regional Perfusion: Real-world Experience and Outcomes of DCD Liver Transplantation.胸腹常温区域灌注:DCD肝移植的真实世界经验与结果
Transplant Direct. 2025 Feb 28;11(3):e1767. doi: 10.1097/TXD.0000000000001767. eCollection 2025 Mar.
10
Thoracoabdominal Normothermic Regional Perfusion and Donation After Circulatory Death Lung Use.胸腹常温区域灌注与循环死亡后供肺的使用
JAMA Netw Open. 2025 Feb 3;8(2):e2460033. doi: 10.1001/jamanetworkopen.2024.60033.
From Haphazard to a Sustainable Normothermic Regional Perfusion Service: A Blueprint for the Introduction of Novel Perfusion Technologies.
从随意到可持续的常温区域性灌注服务:新型灌注技术引入的蓝图。
Transpl Int. 2022 Jun 3;35:10493. doi: 10.3389/ti.2022.10493. eCollection 2022.
4
Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.美国肝移植中丙型肝炎阳性供体的利用情况存在差异,但结局更优:OPTN/UNOS 数据库分析。
Transplantation. 2022 Sep 1;106(9):1787-1798. doi: 10.1097/TP.0000000000004116. Epub 2022 Apr 6.
5
Early United States experience with liver donation after circulatory determination of death using thoraco-abdominal normothermic regional perfusion: A multi-institutional observational study.早期美国使用胸腹腔常温区域灌注法在循环判定死亡后进行肝捐献的经验:一项多机构观察性研究。
Clin Transplant. 2022 Jun;36(6):e14659. doi: 10.1111/ctr.14659. Epub 2022 Apr 11.
6
OPTN/SRTR 2020 Annual Data Report: Pancreas.器官获取与移植网络/器官共享联合网络2020年度数据报告:胰腺
Am J Transplant. 2022 Mar;22 Suppl 2:137-203. doi: 10.1111/ajt.16979.
7
OPTN/SRTR 2020 Annual Data Report: Liver.OPTN/SRTR 2020 年度数据报告:肝脏。
Am J Transplant. 2022 Mar;22 Suppl 2:204-309. doi: 10.1111/ajt.16978.
8
OPTN/SRTR 2020 Annual Data Report: DOD.器官获取与移植网络/器官共享联合网络2020年年度数据报告:国防部
Am J Transplant. 2022 Mar;22 Suppl 2:519-552. doi: 10.1111/ajt.16976.
9
OPTN/SRTR 2020 Annual Data Report: Kidney.OPTN/SRTR 2020 年度数据报告:肾脏。
Am J Transplant. 2022 Mar;22 Suppl 2:21-136. doi: 10.1111/ajt.16982.
10
Liver Transplantation Outcomes From Controlled Circulatory Death Donors: SCS vs in situ NRP vs ex situ NMP.控制性循环死亡供体的肝移植结局:SCS 与原位 NRP 与体外 NMP。
Ann Surg. 2022 Jun 1;275(6):1156-1164. doi: 10.1097/SLA.0000000000005428. Epub 2022 Mar 3.